<VariationArchive RecordType="classified" VariationID="265125" VariationName="NM_015065.3(EXPH5):c.5786del (p.Pro1929fs)" VariationType="Deletion" Accession="VCV000265125" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2016-10-10" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="259976" VariationID="265125">
      <GeneList>
        <Gene Symbol="EXPH5" FullName="exophilin 5" GeneID="23086" HGNC_ID="HGNC:30578" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108505435" stop="108607536" display_start="108505435" display_stop="108607536" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108376157" stop="108464373" display_start="108376157" display_stop="108464373" Strand="-" />
          </Location>
          <OMIM>612878</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015065.3(EXPH5):c.5786del (p.Pro1929fs)</Name>
      <CanonicalSPDI>NC_000011.10:108509720:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108509721" stop="108509721" display_start="108509721" display_stop="108509721" variantLength="1" positionVCF="108509720" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108380448" stop="108380448" display_start="108380448" display_stop="108380448" variantLength="1" positionVCF="108380447" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P1922fs</ProteinChange>
      <ProteinChange>P1929fs</ProteinChange>
      <ProteinChange>P1741fs</ProteinChange>
      <ProteinChange>P1773fs</ProteinChange>
      <ProteinChange>P1853fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.108509723del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.108509723del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.108380450del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.108380450del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042852.1" sequenceAccession="NG_042852" sequenceVersion="1" change="g.89018del">
            <Expression>NG_042852.1:g.89018del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144763.2" sequenceAccession="NM_001144763" sequenceVersion="2" change="c.5558del">
            <Expression>NM_001144763.2:c.5558del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138235.1" sequenceAccession="NP_001138235" sequenceVersion="1" change="p.Pro1853fs">
            <Expression>NP_001138235.1:p.Pro1853fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144764.2" sequenceAccession="NM_001144764" sequenceVersion="2" change="c.5318del">
            <Expression>NM_001144764.2:c.5318del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138236.1" sequenceAccession="NP_001138236" sequenceVersion="1" change="p.Pro1773fs">
            <Expression>NP_001138236.1:p.Pro1773fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144765.2" sequenceAccession="NM_001144765" sequenceVersion="2" change="c.5222del">
            <Expression>NM_001144765.2:c.5222del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138237.1" sequenceAccession="NP_001138237" sequenceVersion="1" change="p.Pro1741fs">
            <Expression>NP_001138237.1:p.Pro1741fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001308019.2" sequenceAccession="NM_001308019" sequenceVersion="2" change="c.5765del">
            <Expression>NM_001308019.2:c.5765del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001294948.1" sequenceAccession="NP_001294948" sequenceVersion="1" change="p.Pro1922fs">
            <Expression>NP_001294948.1:p.Pro1922fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015065.3" sequenceAccession="NM_015065" sequenceVersion="3" change="c.5786del" MANESelect="true">
            <Expression>NM_015065.3:c.5786del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055880.2" sequenceAccession="NP_055880" sequenceVersion="2" change="p.Pro1929fs">
            <Expression>NP_055880.2:p.Pro1929fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015065.2" sequenceAccession="NM_015065" sequenceVersion="2" change="c.5786delC">
            <Expression>NM_015065.2:c.5786delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA6267278" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="612878.0001" DB="OMIM" />
        <XRef Type="rs" ID="749309384" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015065.3(EXPH5):c.5786del (p.Pro1929fs) AND not provided" Accession="RCV000255148" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015065.3(EXPH5):c.5786del (p.Pro1929fs) AND Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive" Accession="RCV001787092" Version="1">
        <ClassifiedConditionList TraitSetID="9182">
          <ClassifiedCondition DB="MedGen" ID="C3554367">Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-10-10" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23176819</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32176379</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9182" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17561" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, nonspecific, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive</ElementValue>
                <XRef ID="MONDO:0014014" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBS4</ElementValue>
                <XRef Type="MIM" ID="615028" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="412189" DB="Orphanet" />
              <XRef ID="C3554367" DB="MedGen" />
              <XRef ID="MONDO:0014014" DB="MONDO" />
              <XRef Type="MIM" ID="615028" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="93622" SubmissionDate="2021-10-29" DateLastUpdated="2021-11-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612878.0001_EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE" title="EXPH5, 1-BP DEL, 5786C (rs749309384)_EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000056426" DateUpdated="2021-11-05" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-12-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 affected sibs from a consanguineous Iraqi family with inherited skin fragility (EBS4; 615028), McGrath et al. (2012) identified homozygosity for a 1-bp deletion (c.5786delC, NM_015065.2) in exon 6 of the EXPH5 gene, causing a frameshift predicted to result in a premature termination codon truncating the protein by 52 residues (Pro1929LeufsTer8). The mutation segregated with disease in the family and was not found in 200 control chromosomes from mixed Iraqi, Iranian, Kuwaiti, and Omani populations. Patient keratinocytes showed disruption of the keratin filament network and more cortically distributed F-actin as well as significantly reduced cell adhesion compared to wildtype keratinocytes.</Attribute>
              <Citation>
                <ID Source="PubMed">23176819</ID>
              </Citation>
              <XRef DB="OMIM" ID="615028" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 3-year-old Italian girl with epidermolysis bullosa simplex, Diociaiuti et al. (2020) identified homozygosity for the c.5786delC mutation in the EXPH5 gene. Her unaffected consanguineous parents were heterozygous for the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">32176379</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EXPH5" />
          </GeneList>
          <Name>EXPH5, 1-BP DEL, 5786C (rs749309384)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 5786C (rs749309384)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612878.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="616261" SubmissionDate="2022-08-10" DateLastUpdated="2023-03-04" DateCreated="2016-10-10">
        <ClinVarSubmissionID localKey="GDXSV:235573" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000321608" DateUpdated="2023-03-04" DateCreated="2016-10-10" Type="SCV" Version="8" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Analysis of a skin biopsy from one affected sibling showed loss of EXPH5 immunostaining, disruption of keratinocyte adhesion within the lower epidermis, and an increased number of perinuclear vesicles (McGrath et al., 2012); Frameshift variant predicted to result in protein truncation as the last 61 amino acids are replaced with 7 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 23176819, 26211931, 34426522, 32176379, 33274474)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EXPH5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:20024</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015065.2:c.5786del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_123_20220810054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="93622" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA SIMPLEX 4, LOCALIZED OR GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C3554367" Name="Epidermolysis bullosa simplex 4, localized or generalized intermediate, autosomal recessive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="616261" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

